Stock 4163 AL-DAWAA MEDICAL SERVICES COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Al-Dawaa Medical Services Company

Equities

4163

SA15H14I11H6

Drug Retailers

Delayed Saudi Arabian S.E.
Other stock markets
 03:02:59 2024-06-30 EDT 		5-day change 1st Jan Change
87.5 SAR +0.34% Intraday chart for Al-Dawaa Medical Services Company +1.63% -17.39%
06-06 Aldawaa, Mouwasat Form New Limited Liability Company in Medical Clinics MT
06-06 Al Dawaa Medical Services Company Announces the Establishment of Limited Liability Company in Partnership with Mouwasat Medical Services Company CI

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 6,112 8,993 7,412 - -
Enterprise Value (EV) 1 6,112 11,093 8,886 8,882 8,866
P/E ratio 20 x 27.3 x 18.6 x 15.8 x 14.3 x
Yield - - 3.31% 3.73% 4.51%
Capitalization / Revenue 1.14 x 1.57 x 1.19 x 1.12 x 1.05 x
EV / Revenue 1.14 x 1.93 x 1.43 x 1.34 x 1.26 x
EV / EBITDA 8.45 x 13.4 x 9.72 x 9.09 x 8.62 x
EV / FCF - 21.8 x 18.7 x 17.9 x 18.2 x
FCF Yield - 4.59% 5.36% 5.58% 5.49%
Price to Book - 6.85 x 5.32 x 4.75 x 4.38 x
Nbr of stocks (in thousands) 85,000 85,000 85,000 - -
Reference price 2 71.90 105.8 87.20 87.20 87.20
Announcement Date 23-03-26 24-03-18 - - -
1SAR in Million2SAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 5,034 5,372 5,741 6,207 6,604 7,052
EBITDA 1 - 600.1 723.6 830.4 914.3 977.5 1,029
EBIT 1 - 266.2 369 466.7 532.9 567.7 617.9
Operating Margin - 5.29% 6.87% 8.13% 8.59% 8.6% 8.76%
Earnings before Tax (EBT) 1 - 246 - 342.4 415.5 502.3 550
Net income 1 246.4 239.1 305.4 329.2 399.7 470.8 518.4
Net margin - 4.75% 5.69% 5.73% 6.44% 7.13% 7.35%
EPS 2 1,232 2.810 3.590 3.870 4.684 5.536 6.097
Free Cash Flow 1 - 291.7 - 508.9 476.3 495.7 486.5
FCF margin - 5.79% - 8.86% 7.67% 7.51% 6.9%
FCF Conversion (EBITDA) - 48.6% - 61.28% 52.1% 50.71% 47.28%
FCF Conversion (Net income) - 121.96% - 154.58% 119.18% 105.27% 93.85%
Dividend per Share 2 - 4.130 - - 2.890 3.254 3.935
Announcement Date 21-12-22 22-03-31 23-03-26 24-03-18 - - -
1SAR in Million2SAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 - 1,439 1,458 1,516
EBITDA - - 215.6 -
EBIT 1 - 102 127.7 130.5
Operating Margin - 7.09% 8.76% 8.61%
Earnings before Tax (EBT) - - - -
Net income 1 89.33 71.28 92.35 95.33
Net margin - 4.95% 6.33% 6.29%
EPS 1.050 - - -
Dividend per Share - - - -
Announcement Date 23-08-03 23-11-02 24-03-18 24-04-29
1SAR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 2,100 1,474 1,470 1,454
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - - - 2.528 x 1.613 x 1.504 x 1.413 x
Free Cash Flow 1 - 292 - 509 476 496 487
ROE (net income / shareholders' equity) - 22.8% - 27.3% 29.8% 30.6% 30.7%
ROA (Net income/ Total Assets) - 6.31% - 7.15% 8.19% 9.33% 9.21%
Assets 1 - 3,788 - 4,602 4,880 5,049 5,627
Book Value Per Share 2 - 11.60 - 15.40 16.40 18.40 19.90
Cash Flow per Share - - - - - - -
Capex 1 - 378 - 217 223 235 228
Capex / Sales - 7.52% - 3.78% 3.59% 3.56% 3.23%
Announcement Date 21-12-22 22-03-31 23-03-26 24-03-18 - - -
1SAR in Million2SAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Al-Dawaa Medical Services Company

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
87.2 SAR
Average target price
113.3 SAR
Spread / Average Target
+29.97%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
AL-DAWAA MEDICAL SERVICES COMPANY Stock Al-Dawaa Medical Services Company
-17.58% 1.98B
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-53.68% 10.44B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-45.65% 8.68B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-26.18% 6.45B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-7.49% 5.98B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+85.61% 4.91B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-3.80% 4.57B
CLICKS GROUP LIMITED Stock Clicks Group Limited
+5.73% 4.49B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
-26.42% 4.1B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-18.65% 2.58B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 4163 Stock
  4. Financials Al-Dawaa Medical Services Company